Login / Signup

Clinical outcome and safety profile of rituximab for the treatment of Dipeptidyl peptidase 4 inhibitors-induced Bullous pemphigoid.

Lula María Nieto-BenitoMarta Bergón-SendínAna Pulido-PérezRicardo M Suárez-Fernández
Published in: Experimental dermatology (2021)
Keyphrases
  • high glucose
  • diffuse large b cell lymphoma
  • diabetic rats
  • oxidative stress
  • combination therapy
  • smoking cessation